Severe combined immune deficiency

  • Thread starter Thread starter Monique
  • Start date Start date
AI Thread Summary
The discussion highlights concerns regarding the safety of retroviral gene therapy, particularly in the context of severe combined immune deficiency (SCID) patients. Out of 15 patients treated, two developed leukemia due to the integration of the retrovirus into the LMO-2 gene, raising questions about the risks of gene therapy. While some viruses, like adenoviruses, do not integrate into the genome, they carry significant immunological risks. The conversation also explores the possibility of targeting viral integration to specific "junk regions" of the genome to mitigate risks. It references Derek Lowe's article, which suggests that the distribution of viral attachment points is not random, particularly near leukemia-related sites. This non-random distribution warrants further investigation, as it could explain the observed mutations and their implications for patient outcomes. The discussion concludes with inquiries about the methods used to identify faulty genes and the potential existence of other defective genes in the affected patients.
Monique
Staff Emeritus
Science Advisor
Gold Member
Messages
4,211
Reaction score
68
I thought it was interesting to note that out of 15 SCID (severe combined immune deficiency) patients cured by retroviral gene therapy, 2 developed leukemia.

This as a direct integration of the virus into a pro-oncogene, the interesting thing is that both patients had an insert in the same gene! (LMO-2)

This poses questions on the safety of gene therapy. Ofcourse, not all virusses integrate themselves into the genome (like adeno, or adeno-associated virusses) but those other ones bring severe immunological risks with them..


I wonder, wouldn't it be possible to target a virus to a specific 'junk region' of the genome? I am not sure how virusses integrate themselves, they probably depend on regions with less dense histone packing..
 
Biology news on Phys.org
Derek Lowe's article

http://www.corante.com/pipeline/ had an article about this a month or so ago - you might have to look in his archives for it. Basically what he said is that the attachment links are not randomly distributed in the chromosome, and that the probablility that your vector will attach near a leukemia site cannot be estimated by uniform distribution, which is what the experimentalists did. How the attachment points really are distributed, and why they seem to nestle close to leukemia sites is material for future research.
 
Last edited by a moderator:
I looked in the archives, but didn't find anything.

So how did these researchers know it is not uniformly distributed and is not random? I agree that lightning striking the same spot twice is suspicious, but since these are specific blood cells which will require a specific growth hormone, it might not be that striking that cells with this particular mutation have a growth advantage.

How did they find this gene in particular to be faulty anyway? Maybe there are a dozen more of the same genes defective in the same patients?
 
I'll see if I can find the paper/
 
Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S. According to articles in the Los Angeles Times, "Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S.", and "Kissing bugs bring deadly disease to California". LA Times requires a subscription. Related article -...
I am reading Nicholas Wade's book A Troublesome Inheritance. Please let's not make this thread a critique about the merits or demerits of the book. This thread is my attempt to understanding the evidence that Natural Selection in the human genome was recent and regional. On Page 103 of A Troublesome Inheritance, Wade writes the following: "The regional nature of selection was first made evident in a genomewide scan undertaken by Jonathan Pritchard, a population geneticist at the...

Similar threads

Replies
19
Views
9K
Replies
2
Views
7K
Back
Top